GENCONTUSS (KRAMER NOVIS)


Welcome to the PulseAid listing for the GENCONTUSS drug offered from KRAMER NOVIS. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: KRAMER NOVIS
NON-PROPRIETARY NAME: CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE
SUBSTANCE NAME: CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2015-06-08
END MARKETING DATE: 0000-00-00


GENCONTUSS HUMAN OTC DRUG Details:

Item DescriptionGENCONTUSS from KRAMER NOVIS
LABELER NAME: KRAMER NOVIS
DEA SCHEDULE:
ACTIVE STRENGTH: 2; 10; 5(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2015-06-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52083-650_12ea5981-7b12-439f-8c75-174002601cdb
PRODUCT NDC: 52083-650
APPLICATION NUMBER: part341

Other CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Advanced Generic CorporationBIO-RYTUSS
EDWARDS PHARMACEUTICALS, INC.ED-A-HIST DM
KRAMER NOVISGENCONTUSS
Laser Pharmaceuticals, LLCDonatussin
Okendpharma, Inc.Rycontuss
Portal PharmaceuticalBronkids
US Pharmaceutical CorporationNorelCS